Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LITE: Liposomal Doxorubicin vs Epirubicin in Breast Cancer
NCT00531973Phase 4Unknown
- Sponsor
- The Catholic University of America
- Start
- Jan 2007
- Primary completion
- Aug 2008
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of doxorubicin in breast cancer, sponsored by The Catholic University of America. Primary endpoint: Pulsed-Wave Tissue Doppler Imaging systolic function parameters at 12 months. Status: unknown.
02
Drugs
doxorubicin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00531973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00531973.